Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

about

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

Item

http://www.wikidata.org/entity/Q59135667

description

scientific article published on 14 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@en

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@nl

type

Item

label

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@en

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@nl

prefLabel

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@en

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@nl

P1476

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate

@en

P2093

Angelo Zinellu

http://www.w3.org/2001/XMLSchema#string

Ciriaco Carru

http://www.w3.org/2001/XMLSchema#string

Gian Luca Erre

http://www.w3.org/2001/XMLSchema#string

Matteo Piga

http://www.w3.org/2001/XMLSchema#string

Sara Tommasi

http://www.w3.org/2001/XMLSchema#string

P2860

From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection

AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis

Inflammation and atherosclerosis

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Role of cytokines in rheumatoid arthritis

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.

P304

212557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7573/DIC.212557

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Sotgia

Arduino A Mangoni

P577

2018-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30459819

http://www.w3.org/2001/XMLSchema#string

P921

molecular medicine

P932

6239018

http://www.w3.org/2001/XMLSchema#string